にきび治療薬の世界市場2023年~2027年

◆英語タイトル:Global Acne Drugs Market 2023-2027

Technavioが発行した調査報告書(IRTNTR75142-23)◆商品コード:IRTNTR75142-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年3月27日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テックナビオインフィニティリサーチ社は、世界のにきび治療薬市場規模が予測期間中(2022年~2027年)にCAGR 3.46%増加し、907.11百万ドルまで拡大すると予測しています。本書では、にきび治療薬の世界市場を対象に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(処方箋薬、一般用医薬品)分析、投薬経路別(外用、経口)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、イギリス、中国、日本)分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、市場調査の対象になる企業情報には、AndroScience Corp.、Astellas Pharma Inc.、Bayer AG、Cipher Pharmaceuticals Inc.、Cosmo Pharmaceuticals NV、Elorac Inc.、Equalan Pharma Europe Sp. z o.o.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plcなどが含まれております。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界のにきび治療薬市場規模:種類別
- 処方箋薬の市場規模
- 一般用医薬品の市場規模
・世界のにきび治療薬市場規模:投薬経路別
- 外用における市場規模
- 経口における市場規模
・顧客状況
・世界のにきび治療薬市場規模:地域別
- 北米のにきび治療薬市場規模
- ヨーロッパのにきび治療薬市場規模
- アジアのにきび治療薬市場規模
- その他地域のにきび治療薬市場規模
- アメリカのにきび治療薬市場規模
- ドイツのにきび治療薬市場規模
- イギリスのにきび治療薬市場規模
- 中国のにきび治療薬市場規模
- 日本のにきび治療薬市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テックナビオインフィニティリサーチ社は、利益・価格・競争・プロモーションなどの主なパラメーターの分析や、多数の情報源からの情報を調査・統合・総括することによって、にきび治療薬市場の細部にわたる実態を提供します。また、市場の主要インフルエンサーを明らかにすることで、市場の多様な面を提示します。提示された情報は総合的で信頼度が高く、一次・二次の広範囲に行った調査の結果です。 テックナビオインフィニティリサーチ社の市場調査書は、的確なにきび治療薬市場の拡大を推測するために、質的・量的調査を用いた完全な競争状況・詳細なベンダー選択手法・分析を提供します。

にきび治療薬の世界市場 2023-2027

Technavio社は、にきび治療薬市場をモニターしており、2022年から2027年にかけて907.11百万米ドルの成長が予測され、予測期間中のCAGRは3.46%で加速すると予測しています。

当レポートでは、にきび治療薬市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、診断モダリティの向上、新しいにきび治療薬の発売、にきび症例の増加によって牽引されています。

Technavioのにきび治療薬市場は以下のように区分されます:

・タイプ別:
– 処方薬
– OTC医薬品

・投与経路別:
– 外用薬
– 経口

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間におけるにきび治療薬市場の成長を促進する主な要因の一つとして、皮膚疾患に対する遺伝子治療の研究が増加していることを挙げています。また、ベンダーによる無機的な成長戦略とにきび治療における技術革新は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、にきび治療薬市場について以下の分野をカバーします:
– にきび治療薬市場のサイジング
– にきび治療薬市場の予測
– にきび治療薬市場の産業分析

確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AndroScience Corp., Astellas Pharma Inc., Bayer AG, Cipher Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Elorac Inc., Equalan Pharma Europe Sp. z o.o., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Journey Medical Corp., McKesson Corp., Paratek Pharmaceuticals Inc., Photocure ASA, Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Timber Pharmaceuticals LLC, Viatris Inc., and XBiotech Incなどの企業情報が含まれていますまた、にきび治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global acne drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global acne drugs market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Route of administration Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Prescription drugs – Market size and forecast 2022-2027
o Exhibit 34: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
o 6.4 OTC drugs – Market size and forecast 2022-2027
o Exhibit 38: Chart on OTC drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 44: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Route of Administration – Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 46: Chart on Comparison by Route of Administration
o Exhibit 47: Data Table on Comparison by Route of Administration
o 7.3 Topical – Market size and forecast 2022-2027
o Exhibit 48: Chart on Topical – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Topical – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Topical – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Topical – Year-over-year growth 2022-2027 (%)
o 7.4 Oral – Market size and forecast 2022-2027
o Exhibit 52: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 56: Market opportunity by Route of Administration ($ million)
o Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share by geography 2022-2027 (%)
o Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 99: Market opportunity by geography ($ million)
o Exhibit 100: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AndroScience Corp.
o Exhibit 107: AndroScience Corp. – Overview
o Exhibit 108: AndroScience Corp. – Product / Service
o Exhibit 109: AndroScience Corp. – Key offerings
o 12.4 Astellas Pharma Inc.
o Exhibit 110: Astellas Pharma Inc. – Overview
o Exhibit 111: Astellas Pharma Inc. – Product / Service
o Exhibit 112: Astellas Pharma Inc. – Key news
o Exhibit 113: Astellas Pharma Inc. – Key offerings
o 12.5 Bayer AG
o Exhibit 114: Bayer AG – Overview
o Exhibit 115: Bayer AG – Business segments
o Exhibit 116: Bayer AG – Key news
o Exhibit 117: Bayer AG – Key offerings
o Exhibit 118: Bayer AG – Segment focus
o 12.6 Cipher Pharmaceuticals Inc.
o Exhibit 119: Cipher Pharmaceuticals Inc. – Overview
o Exhibit 120: Cipher Pharmaceuticals Inc. – Business segments
o Exhibit 121: Cipher Pharmaceuticals Inc. – Key offerings
o Exhibit 122: Cipher Pharmaceuticals Inc. – Segment focus
o 12.7 Cosmo Pharmaceuticals NV
o Exhibit 123: Cosmo Pharmaceuticals NV – Overview
o Exhibit 124: Cosmo Pharmaceuticals NV – Product / Service
o Exhibit 125: Cosmo Pharmaceuticals NV – Key news
o Exhibit 126: Cosmo Pharmaceuticals NV – Key offerings
o 12.8 Elorac Inc.
o Exhibit 127: Elorac Inc. – Overview
o Exhibit 128: Elorac Inc. – Product / Service
o Exhibit 129: Elorac Inc. – Key offerings
o 12.9 Equalan Pharma Europe Sp. z o.o.
o Exhibit 130: Equalan Pharma Europe Sp. z o.o. – Overview
o Exhibit 131: Equalan Pharma Europe Sp. z o.o. – Product / Service
o Exhibit 132: Equalan Pharma Europe Sp. z o.o. – Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 138: GlaxoSmithKline Plc – Overview
o Exhibit 139: GlaxoSmithKline Plc – Business segments
o Exhibit 140: GlaxoSmithKline Plc – Key news
o Exhibit 141: GlaxoSmithKline Plc – Key offerings
o Exhibit 142: GlaxoSmithKline Plc – Segment focus
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 143: Johnson and Johnson Services Inc. – Overview
o Exhibit 144: Johnson and Johnson Services Inc. – Business segments
o Exhibit 145: Johnson and Johnson Services Inc. – Key news
o Exhibit 146: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 147: Johnson and Johnson Services Inc. – Segment focus
o 12.13 Journey Medical Corp.
o Exhibit 148: Journey Medical Corp. – Overview
o Exhibit 149: Journey Medical Corp. – Product / Service
o Exhibit 150: Journey Medical Corp. – Key offerings
o 12.14 Paratek Pharmaceuticals Inc.
o Exhibit 151: Paratek Pharmaceuticals Inc. – Overview
o Exhibit 152: Paratek Pharmaceuticals Inc. – Product / Service
o Exhibit 153: Paratek Pharmaceuticals Inc. – Key offerings
o 12.15 Photocure ASA
o Exhibit 154: Photocure ASA – Overview
o Exhibit 155: Photocure ASA – Product / Service
o Exhibit 156: Photocure ASA – Key offerings
o 12.16 Timber Pharmaceuticals LLC
o Exhibit 157: Timber Pharmaceuticals LLC – Overview
o Exhibit 158: Timber Pharmaceuticals LLC – Product / Service
o Exhibit 159: Timber Pharmaceuticals LLC – Key offerings
o 12.17 Viatris Inc.
o Exhibit 160: Viatris Inc. – Overview
o Exhibit 161: Viatris Inc. – Business segments
o Exhibit 162: Viatris Inc. – Key offerings
o Exhibit 163: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global acne drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on OTC drugs – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits45: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Topical – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Topical – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Topical – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Topical – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2022-2027 (%)
Exhibits60: Data Table on Market share by geography 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity by geography ($ million)
Exhibits100: Data Tables on Market opportunity by geography ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AndroScience Corp. – Overview
Exhibits108: AndroScience Corp. – Product / Service
Exhibits109: AndroScience Corp. – Key offerings
Exhibits110: Astellas Pharma Inc. – Overview
Exhibits111: Astellas Pharma Inc. – Product / Service
Exhibits112: Astellas Pharma Inc. – Key news
Exhibits113: Astellas Pharma Inc. – Key offerings
Exhibits114: Bayer AG – Overview
Exhibits115: Bayer AG – Business segments
Exhibits116: Bayer AG – Key news
Exhibits117: Bayer AG – Key offerings
Exhibits118: Bayer AG – Segment focus
Exhibits119: Cipher Pharmaceuticals Inc. – Overview
Exhibits120: Cipher Pharmaceuticals Inc. – Business segments
Exhibits121: Cipher Pharmaceuticals Inc. – Key offerings
Exhibits122: Cipher Pharmaceuticals Inc. – Segment focus
Exhibits123: Cosmo Pharmaceuticals NV – Overview
Exhibits124: Cosmo Pharmaceuticals NV – Product / Service
Exhibits125: Cosmo Pharmaceuticals NV – Key news
Exhibits126: Cosmo Pharmaceuticals NV – Key offerings
Exhibits127: Elorac Inc. – Overview
Exhibits128: Elorac Inc. – Product / Service
Exhibits129: Elorac Inc. – Key offerings
Exhibits130: Equalan Pharma Europe Sp. z o.o. – Overview
Exhibits131: Equalan Pharma Europe Sp. z o.o. – Product / Service
Exhibits132: Equalan Pharma Europe Sp. z o.o. – Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. – Overview
Exhibits134: F. Hoffmann La Roche Ltd. – Business segments
Exhibits135: F. Hoffmann La Roche Ltd. – Key news
Exhibits136: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits138: GlaxoSmithKline Plc – Overview
Exhibits139: GlaxoSmithKline Plc – Business segments
Exhibits140: GlaxoSmithKline Plc – Key news
Exhibits141: GlaxoSmithKline Plc – Key offerings
Exhibits142: GlaxoSmithKline Plc – Segment focus
Exhibits143: Johnson and Johnson Services Inc. – Overview
Exhibits144: Johnson and Johnson Services Inc. – Business segments
Exhibits145: Johnson and Johnson Services Inc. – Key news
Exhibits146: Johnson and Johnson Services Inc. – Key offerings
Exhibits147: Johnson and Johnson Services Inc. – Segment focus
Exhibits148: Journey Medical Corp. – Overview
Exhibits149: Journey Medical Corp. – Product / Service
Exhibits150: Journey Medical Corp. – Key offerings
Exhibits151: Paratek Pharmaceuticals Inc. – Overview
Exhibits152: Paratek Pharmaceuticals Inc. – Product / Service
Exhibits153: Paratek Pharmaceuticals Inc. – Key offerings
Exhibits154: Photocure ASA – Overview
Exhibits155: Photocure ASA – Product / Service
Exhibits156: Photocure ASA – Key offerings
Exhibits157: Timber Pharmaceuticals LLC – Overview
Exhibits158: Timber Pharmaceuticals LLC – Product / Service
Exhibits159: Timber Pharmaceuticals LLC – Key offerings
Exhibits160: Viatris Inc. – Overview
Exhibits161: Viatris Inc. – Business segments
Exhibits162: Viatris Inc. – Key offerings
Exhibits163: Viatris Inc. – Segment focus
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ にきび治療薬の世界市場2023年~2027年(Global Acne Drugs Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆